ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway

ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis

(2020) Hong Liu et al.   CANCER CELL

Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

(2020) Bin Li et al.   Frontiers in Immunology

N6-adenosine methylation of ribosomal RNA affects lipid oxidation and stress resistance

(2020) Noa Liberman et al.   Science Advances

Increased adenosine-to-inosine RNA editing in rheumatoid arthritis

(2019) Nikolaos I. Vlachogiannis et al.   JOURNAL OF AUTOIMMUNITY

Metformin suppresses CRC growth by inducing apoptosis via ADORA1

(2017) Bin Lan   Frontiers in Bioscience-Landmark

Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy

(2016) Jun Huang et al.   NEUROCHEMICAL RESEARCH

Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway

(2016) Vassiliki A. Boussiotis   NEW ENGLAND JOURNAL OF MEDICINE

Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration

(2016) Patrycja Koszałka et al.   PLoS One

Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma

(2015) Yasuhiro Nakajima et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches

(2015) Tim F Greten et al.   GUT

Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance

(2012) Edita Aksamitiene et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

(2012) Augusto Villanueva et al.   Nature Reviews Gastroenterology & Hepatology

Adenosine A1 receptor, a target and regulator of estrogen receptorα action, mediates the proliferative effects of estradiol in breast cancer

(2009) Z Lin et al.   ONCOGENE

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

(2008) György Haskó et al.   NATURE REVIEWS DRUG DISCOVERY